Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Alzheimer's Disease Therapeutics. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102264672A details a scalable route to chiral phenols using Ru-catalyzed transfer hydrogenation, offering cost reduction and high purity for pharmaceutical manufacturing.
Analyzing the palladium-free copper-catalyzed route for benzimidazole nitrene synthesis. Discover how modern optimization achieves 84% yields while avoiding toxic metals and strong oxidants.